Company / Capital Expenditures
Encompass Health Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$736.4M
FY2025
5-year range
$524.6M / $736.4M
FY2021-FY2025
Trend
+14.6%
vs FY2024
Sector context
#15 of 151
Health Care
What the data says
Among 151 Health Care companies, Encompass Health is in the top 10% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $178M in FY2018 to $736M in FY2025.
Based on SEC 10-K filings.
$736M in FY2025 with a 5-year CAGR of +13.4%. Top quartile in the Health Care sector.
Improved from $546M to $736M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +9.2%
- 5-Year CAGR
- +13.4%
- 10-Year CAGR
- -
Sector benchmark
+171.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +13.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 14.6% year-over-year.
- Ranks #15 out of 151 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $736.4M | +14.6% |
| FY2024 | $642.5M | +17.7% |
| FY2023 | $545.7M | -3.4% |
| FY2022 | $564.8M | +7.7% |
| FY2021 | $524.6M | +33.6% |
| FY2020 | $392.8M | +74.0% |
| FY2019 | $225.8M | +27.1% |
| FY2018 | $177.7M | -21.3% |
| FY2017 | $225.8M | +27.1% |
| FY2016 | $177.7M | +38.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026